Form 6-K Collective Mining Ltd. For: May 13
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May, 2026
Commission File Number: 001-42170
Collective Mining Ltd.
(Translation of registrant’s name into English)
201 South Biscayne Boulevard, Suite 2210
Miami, FL 33131
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☐ Form 40-F ☒
This report on Form 6-K is being furnished for the sole purpose of providing copies of various consents, undertakings and non-issuer forms of submission to jurisdiction and appointment of agent for service of process filed on Sedar+ on May 13, 2026 by Collective Mining Ltd. in connection with the filing of its Final Short Form Base Shelf Prospectus.
EXHIBIT INDEX
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Collective Mining Ltd. | ||
| Date: May 13, 2026 | By: | /s/ Paul Begin |
| Name: | Paul Begin | |
| Title: | Chief Financial Officer and Corporate Secretary | |
2
ATTACHMENTS / EXHIBITS
CONSENT OF STEWART D. REDWOOD DATED MAY 12, 2026
CONSENT OF BDO CANADA DATED MAY 12, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PB2 Foods Introduces New PB2Go Cups, Bringing High-Protein Peanut Butter Snacking Anywhere
- XTEND Secures UAV Patent and Files Amended S-4 as Merger with JFB Construction Holdings Advances Toward Q3 2026 Close
- Ascletis Announces U.S. FDA IND Clearance for Phase I Study of Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for the Treatment of Obesity
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share